The Union health ministry has directed states to act against unauthorized stem cell therapy. It reiterated that such treatments are only for approved disease conditions. Stem cell therapy for autism spectrum disorder must remain restricted to clinical trials. Non-compliance with these directions can attract professional misconduct and penalties. Authorities must ensure unproven stem cell interventions are not offered outside the regulatory framework.